risperidone has been researched along with Agoraphobia in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rapinesi, C | 1 |
| Serata, D | 1 |
| Del Casale, A | 1 |
| Kotzalidis, GD | 1 |
| Romano, S | 1 |
| Milioni, M | 1 |
| Capezzuto, S | 1 |
| Carbonetti, P | 1 |
| Angeletti, G | 1 |
| Fensore, C | 1 |
| Tatarelli, R | 1 |
| Girardi, P | 1 |
1 other study available for risperidone and Agoraphobia
| Article | Year |
|---|---|
Electroconvulsive therapy in a physically restrained man with comorbid major depression, severe agoraphobia with panic disorder, and histrionic personality disorder.
Topics: Adult; Agoraphobia; Antimanic Agents; Antipsychotic Agents; Depressive Disorder, Major; Electroconvu | 2012 |